Vaxil Bio Stock Buy Hold or Sell Recommendation
VXLLF Stock | USD 0.01 0.0003 6.00% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Vaxil Bio is 'Strong Sell'. Macroaxis provides Vaxil Bio buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding VXLLF positions. The advice algorithm takes into account all of Vaxil Bio's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Vaxil Bio's buy or sell advice are summarized below:
Real Value 0.005088 | Hype Value 0.007074 | Market Value 0.0053 | Naive Value 0.003481 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Vaxil Bio given historical horizon and risk tolerance towards Vaxil Bio. When Macroaxis issues a 'buy' or 'sell' recommendation for Vaxil Bio, the advice is generated through an automated system that utilizes algorithms and statistical models.
Vaxil |
Execute Vaxil Bio Buy or Sell Advice
The Vaxil recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Vaxil Bio. Macroaxis does not own or have any residual interests in Vaxil Bio or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Vaxil Bio's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Moves completely opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Vaxil Bio Trading Alerts and Improvement Suggestions
Vaxil Bio generated a negative expected return over the last 90 days | |
Vaxil Bio has high historical volatility and very poor performance | |
Vaxil Bio has some characteristics of a very speculative penny stock | |
Vaxil Bio has high likelihood to experience some financial distress in the next 2 years | |
Net Loss for the year was (986 K) with profit before overhead, payroll, taxes, and interest of 0. | |
Vaxil Bio has accumulated about 1.84 M in cash with (1.08 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Vaxil Bio Returns Distribution Density
The distribution of Vaxil Bio's historical returns is an attempt to chart the uncertainty of Vaxil Bio's future price movements. The chart of the probability distribution of Vaxil Bio daily returns describes the distribution of returns around its average expected value. We use Vaxil Bio price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Vaxil Bio returns is essential to provide solid investment advice for Vaxil Bio.
Mean Return | -0.11 | Value At Risk | -36.36 | Potential Upside | 7.53 | Standard Deviation | 20.14 |
Return Density |
Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Vaxil Bio historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Vaxil Bio Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Vaxil Bio or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Vaxil Bio's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Vaxil pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 0.20 | |
β | Beta against NYSE Composite | -3.78 | |
σ | Overall volatility | 20.82 | |
Ir | Information ratio | -0.01 |
Vaxil Bio Volatility Alert
Vaxil Bio is displaying above-average volatility over the selected time horizon. Vaxil Bio is a penny stock. Even though Vaxil Bio may be a good instrument to invest, many penny pink sheets are speculative instruments that are subject to artificial stock promotions. Please make sure you fully understand upside and downside scenarios of investing in Vaxil Bio or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings,sudden promotions and many other similar artificial hype indicators. We also encourage traders to check work history of company executives before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Vaxil instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Vaxil Bio Fundamentals Vs Peers
Comparing Vaxil Bio's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Vaxil Bio's direct or indirect competition across all of the common fundamentals between Vaxil Bio and the related equities. This way, we can detect undervalued stocks with similar characteristics as Vaxil Bio or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Vaxil Bio's fundamental indicators could also be used in its relative valuation, which is a method of valuing Vaxil Bio by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare Vaxil Bio to competition |
Fundamentals | Vaxil Bio | Peer Average |
Return On Equity | -0.43 | -0.31 |
Return On Asset | -0.21 | -0.14 |
Current Valuation | 908.6 K | 16.62 B |
Shares Outstanding | 136.98 M | 571.82 M |
Shares Owned By Insiders | 8.16 % | 10.09 % |
Shares Owned By Institutions | 0.01 % | 39.21 % |
Price To Earning | (1.30) X | 28.72 X |
Price To Book | 2.68 X | 9.51 X |
EBITDA | (961 K) | 3.9 B |
Net Income | (986 K) | 570.98 M |
Cash And Equivalents | 1.84 M | 2.7 B |
Cash Per Share | 0.01 X | 5.01 X |
Total Debt | 9 K | 5.32 B |
Debt To Equity | 0.01 % | 48.70 % |
Current Ratio | 4.16 X | 2.16 X |
Book Value Per Share | 0.01 X | 1.93 K |
Cash Flow From Operations | (1.08 M) | 971.22 M |
Earnings Per Share | (0.01) X | 3.12 X |
Number Of Employees | 2 | 18.84 K |
Beta | -3.43 | -0.15 |
Market Capitalization | 2.04 M | 19.03 B |
Total Asset | 2.29 M | 29.47 B |
Net Asset | 2.29 M |
Vaxil Bio Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Vaxil . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Daily Balance Of Power | 9.2 T | |||
Rate Of Daily Change | 1.06 | |||
Day Median Price | 0.0053 | |||
Day Typical Price | 0.0053 | |||
Price Action Indicator | 1.0E-4 | |||
Period Momentum Indicator | 3.0E-4 | |||
Relative Strength Index | 10.71 |
About Vaxil Bio Buy or Sell Advice
When is the right time to buy or sell Vaxil Bio? Buying financial instruments such as Vaxil Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Vaxil Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Education Thematic Idea Now
Education
Companies involved in apprenticeship, education, tutoring, schooling, online universities, and other learning services. The Education theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Education Theme or any other thematic opportunities.
View All Next | Launch |
Check out Vaxil Bio Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Complementary Tools for Vaxil Pink Sheet analysis
When running Vaxil Bio's price analysis, check to measure Vaxil Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxil Bio is operating at the current time. Most of Vaxil Bio's value examination focuses on studying past and present price action to predict the probability of Vaxil Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxil Bio's price. Additionally, you may evaluate how the addition of Vaxil Bio to your portfolios can decrease your overall portfolio volatility.
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |